Role of Molecular Biology in Diagnostic Pathology of Melanoma View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2001

AUTHORS

Andrzej Slominski , Andrew Carlson , Jacobo Wortsman , Martin C. Mihm

ABSTRACT

Cutaneous melanoma is the most rapidly increasing malignancy in the white European population; its clinical significance is enhanced because it can affect younger individuals (1–3). The high mortality rate among melanoma patients, second to lung cancer, is related to melanoma’s resistance to therapy once the metastastic process has started (4–6). The tumor derives from epidermal melanocytes, either activated or genetically altered; thus, important precursors include activated melanocytes present within solar lentigo or forming prema- lignant lesions such as lentigo maligna (7–10). Melanoma can also arise from relatively benign or atypical nevomelanocyte lesions (7–10). Benign lesions that can nevertheless result in melanoma include congenital melanocytic nevus, nevus of Ota, nevus of Ito, and cellular blue nevus. The atypical lesions with the same possible outcome are represented by acquired dysplastic melanocytic nevus, melanocytic dysplasia on the acral or mucosal surface, spindle cell and/or atypical epithelioid melanocytic nevus (Spitz nevus), and dysplastic and/or congenital nevus spilus (7–10). More... »

PAGES

123-163

Identifiers

URI

http://scigraph.springernature.com/pub.10.1385/1-59259-145-0:123

DOI

http://dx.doi.org/10.1385/1-59259-145-0:123

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1010584113

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22323256


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Loyola University Medical Center, Maywood, IL", 
          "id": "http://www.grid.ac/institutes/grid.411451.4", 
          "name": [
            "Department of Pathology, Loyola University Medical Center, Maywood, IL"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Slominski", 
        "givenName": "Andrzej", 
        "id": "sg:person.016612034677.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016612034677.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology and Laboratory Medicine, Albany Medical Center, Albany, NY", 
          "id": "http://www.grid.ac/institutes/grid.413558.e", 
          "name": [
            "Department of Pathology and Laboratory Medicine, Albany Medical Center, Albany, NY"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carlson", 
        "givenName": "Andrew", 
        "id": "sg:person.01346704541.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346704541.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Southern Illinois University, Springfield, IL", 
          "id": "http://www.grid.ac/institutes/grid.280418.7", 
          "name": [
            "Department of Medicine, Southern Illinois University, Springfield, IL"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wortsman", 
        "givenName": "Jacobo", 
        "id": "sg:person.01234140064.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234140064.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Dermatopathology, Massachusetts General Hospital, Boston, MA", 
          "id": "http://www.grid.ac/institutes/grid.32224.35", 
          "name": [
            "Department of Dermatopathology, Massachusetts General Hospital, Boston, MA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mihm", 
        "givenName": "Martin C.", 
        "id": "sg:person.013071656517.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013071656517.06"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2001", 
    "datePublishedReg": "2001-01-01", 
    "description": "Cutaneous melanoma is the most rapidly increasing malignancy in the white European population; its clinical significance is enhanced because it can affect younger individuals (1\u20133). The high mortality rate among melanoma patients, second to lung cancer, is related to melanoma\u2019s resistance to therapy once the metastastic process has started (4\u20136). The tumor derives from epidermal melanocytes, either activated or genetically altered; thus, important precursors include activated melanocytes present within solar lentigo or forming prema- lignant lesions such as lentigo maligna (7\u201310). Melanoma can also arise from relatively benign or atypical nevomelanocyte lesions (7\u201310). Benign lesions that can nevertheless result in melanoma include congenital melanocytic nevus, nevus of Ota, nevus of Ito, and cellular blue nevus. The atypical lesions with the same possible outcome are represented by acquired dysplastic melanocytic nevus, melanocytic dysplasia on the acral or mucosal surface, spindle cell and/or atypical epithelioid melanocytic nevus (Spitz nevus), and dysplastic and/or congenital nevus spilus (7\u201310).", 
    "genre": "chapter", 
    "id": "sg:pub.10.1385/1-59259-145-0:123", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-0-89603-684-0", 
        "978-1-59259-145-9"
      ], 
      "name": "Melanoma Techniques and Protocols", 
      "type": "Book"
    }, 
    "keywords": [
      "melanocytic nevi", 
      "congenital melanocytic nevi", 
      "high mortality rate", 
      "cellular blue nevus", 
      "white European population", 
      "dysplastic melanocytic nevi", 
      "nevus of Ota", 
      "nevus of Ito", 
      "melanoma patients", 
      "cutaneous melanoma", 
      "lung cancer", 
      "clinical significance", 
      "spindle cells", 
      "lentigo maligna", 
      "atypical lesions", 
      "melanocytic dysplasia", 
      "benign lesions", 
      "mortality rate", 
      "blue nevus", 
      "mucosal surfaces", 
      "solar lentigines", 
      "melanoma", 
      "lesions", 
      "nevi", 
      "nevus spilus", 
      "young individuals", 
      "melanoma resistance", 
      "epidermal melanocytes", 
      "diagnostic pathology", 
      "melanocytes", 
      "European populations", 
      "patients", 
      "malignancy", 
      "maligna", 
      "dysplasia", 
      "therapy", 
      "tumors", 
      "cancer", 
      "molecular biology", 
      "pathology", 
      "lentigines", 
      "outcomes", 
      "possible outcomes", 
      "resistance", 
      "cells", 
      "population", 
      "individuals", 
      "significance", 
      "role", 
      "rate", 
      "OTA", 
      "biology", 
      "important precursor", 
      "precursors", 
      "process", 
      "surface", 
      "ITO"
    ], 
    "name": "Role of Molecular Biology in Diagnostic Pathology of Melanoma", 
    "pagination": "123-163", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1010584113"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1385/1-59259-145-0:123"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22323256"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1385/1-59259-145-0:123", 
      "https://app.dimensions.ai/details/publication/pub.1010584113"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-09-02T16:16", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/chapter/chapter_459.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1385/1-59259-145-0:123"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1385/1-59259-145-0:123'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1385/1-59259-145-0:123'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1385/1-59259-145-0:123'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1385/1-59259-145-0:123'


 

This table displays all metadata directly associated to this object as RDF triples.

144 TRIPLES      21 PREDICATES      82 URIs      75 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1385/1-59259-145-0:123 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author Nae109a8d4449475e8f7d19dbff209a68
4 schema:datePublished 2001
5 schema:datePublishedReg 2001-01-01
6 schema:description Cutaneous melanoma is the most rapidly increasing malignancy in the white European population; its clinical significance is enhanced because it can affect younger individuals (1–3). The high mortality rate among melanoma patients, second to lung cancer, is related to melanoma’s resistance to therapy once the metastastic process has started (4–6). The tumor derives from epidermal melanocytes, either activated or genetically altered; thus, important precursors include activated melanocytes present within solar lentigo or forming prema- lignant lesions such as lentigo maligna (7–10). Melanoma can also arise from relatively benign or atypical nevomelanocyte lesions (7–10). Benign lesions that can nevertheless result in melanoma include congenital melanocytic nevus, nevus of Ota, nevus of Ito, and cellular blue nevus. The atypical lesions with the same possible outcome are represented by acquired dysplastic melanocytic nevus, melanocytic dysplasia on the acral or mucosal surface, spindle cell and/or atypical epithelioid melanocytic nevus (Spitz nevus), and dysplastic and/or congenital nevus spilus (7–10).
7 schema:genre chapter
8 schema:isAccessibleForFree false
9 schema:isPartOf Nec955963d54745b5a887ebef9e91a184
10 schema:keywords European populations
11 ITO
12 OTA
13 atypical lesions
14 benign lesions
15 biology
16 blue nevus
17 cancer
18 cells
19 cellular blue nevus
20 clinical significance
21 congenital melanocytic nevi
22 cutaneous melanoma
23 diagnostic pathology
24 dysplasia
25 dysplastic melanocytic nevi
26 epidermal melanocytes
27 high mortality rate
28 important precursor
29 individuals
30 lentigines
31 lentigo maligna
32 lesions
33 lung cancer
34 maligna
35 malignancy
36 melanocytes
37 melanocytic dysplasia
38 melanocytic nevi
39 melanoma
40 melanoma patients
41 melanoma resistance
42 molecular biology
43 mortality rate
44 mucosal surfaces
45 nevi
46 nevus of Ito
47 nevus of Ota
48 nevus spilus
49 outcomes
50 pathology
51 patients
52 population
53 possible outcomes
54 precursors
55 process
56 rate
57 resistance
58 role
59 significance
60 solar lentigines
61 spindle cells
62 surface
63 therapy
64 tumors
65 white European population
66 young individuals
67 schema:name Role of Molecular Biology in Diagnostic Pathology of Melanoma
68 schema:pagination 123-163
69 schema:productId N472afcffcb064414bf7c661dcc5cac05
70 N6feec6767d9141e98c185ea29c067ee5
71 Nb9a13b5068c24967b633d3c34c5d131d
72 schema:publisher Nc49ca5cfea914a2c8b2e1007940a156c
73 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010584113
74 https://doi.org/10.1385/1-59259-145-0:123
75 schema:sdDatePublished 2022-09-02T16:16
76 schema:sdLicense https://scigraph.springernature.com/explorer/license/
77 schema:sdPublisher N342035042002435d9fc04632adeca9fc
78 schema:url https://doi.org/10.1385/1-59259-145-0:123
79 sgo:license sg:explorer/license/
80 sgo:sdDataset chapters
81 rdf:type schema:Chapter
82 N26bbda25a4404006bf9e6e4450cb9a4a rdf:first sg:person.01234140064.27
83 rdf:rest N3bd145cd557f4e759c85cd5da90f17e0
84 N342035042002435d9fc04632adeca9fc schema:name Springer Nature - SN SciGraph project
85 rdf:type schema:Organization
86 N3bd145cd557f4e759c85cd5da90f17e0 rdf:first sg:person.013071656517.06
87 rdf:rest rdf:nil
88 N472afcffcb064414bf7c661dcc5cac05 schema:name doi
89 schema:value 10.1385/1-59259-145-0:123
90 rdf:type schema:PropertyValue
91 N6feec6767d9141e98c185ea29c067ee5 schema:name pubmed_id
92 schema:value 22323256
93 rdf:type schema:PropertyValue
94 Nae109a8d4449475e8f7d19dbff209a68 rdf:first sg:person.016612034677.24
95 rdf:rest Nd4b6915138d24ee1a8e41d19769ef071
96 Nb9a13b5068c24967b633d3c34c5d131d schema:name dimensions_id
97 schema:value pub.1010584113
98 rdf:type schema:PropertyValue
99 Nc49ca5cfea914a2c8b2e1007940a156c schema:name Springer Nature
100 rdf:type schema:Organisation
101 Nd4b6915138d24ee1a8e41d19769ef071 rdf:first sg:person.01346704541.50
102 rdf:rest N26bbda25a4404006bf9e6e4450cb9a4a
103 Nec955963d54745b5a887ebef9e91a184 schema:isbn 978-0-89603-684-0
104 978-1-59259-145-9
105 schema:name Melanoma Techniques and Protocols
106 rdf:type schema:Book
107 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
108 schema:name Medical and Health Sciences
109 rdf:type schema:DefinedTerm
110 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
111 schema:name Oncology and Carcinogenesis
112 rdf:type schema:DefinedTerm
113 sg:person.01234140064.27 schema:affiliation grid-institutes:grid.280418.7
114 schema:familyName Wortsman
115 schema:givenName Jacobo
116 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234140064.27
117 rdf:type schema:Person
118 sg:person.013071656517.06 schema:affiliation grid-institutes:grid.32224.35
119 schema:familyName Mihm
120 schema:givenName Martin C.
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013071656517.06
122 rdf:type schema:Person
123 sg:person.01346704541.50 schema:affiliation grid-institutes:grid.413558.e
124 schema:familyName Carlson
125 schema:givenName Andrew
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346704541.50
127 rdf:type schema:Person
128 sg:person.016612034677.24 schema:affiliation grid-institutes:grid.411451.4
129 schema:familyName Slominski
130 schema:givenName Andrzej
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016612034677.24
132 rdf:type schema:Person
133 grid-institutes:grid.280418.7 schema:alternateName Department of Medicine, Southern Illinois University, Springfield, IL
134 schema:name Department of Medicine, Southern Illinois University, Springfield, IL
135 rdf:type schema:Organization
136 grid-institutes:grid.32224.35 schema:alternateName Department of Dermatopathology, Massachusetts General Hospital, Boston, MA
137 schema:name Department of Dermatopathology, Massachusetts General Hospital, Boston, MA
138 rdf:type schema:Organization
139 grid-institutes:grid.411451.4 schema:alternateName Department of Pathology, Loyola University Medical Center, Maywood, IL
140 schema:name Department of Pathology, Loyola University Medical Center, Maywood, IL
141 rdf:type schema:Organization
142 grid-institutes:grid.413558.e schema:alternateName Department of Pathology and Laboratory Medicine, Albany Medical Center, Albany, NY
143 schema:name Department of Pathology and Laboratory Medicine, Albany Medical Center, Albany, NY
144 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...